loading
Schlusskurs vom Vortag:
$3.08
Offen:
$3.15
24-Stunden-Volumen:
813.54K
Relative Volume:
1.99
Marktkapitalisierung:
$38.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.91M
KGV:
-2.1678
EPS:
-1.49
Netto-Cashflow:
-
1W Leistung:
-17.18%
1M Leistung:
-59.99%
6M Leistung:
-80.33%
1J Leistung:
-85.64%
1-Tages-Spanne:
Value
$2.85
$3.36
1-Wochen-Bereich:
Value
$2.85
$6.463
52-Wochen-Spanne:
Value
$2.40
$49.80

Incannex Healthcare Inc Stock (IXHL) Company Profile

Name
Firmenname
Incannex Healthcare Inc
Name
Telefon
61 409 840 786
Name
Adresse
8 CENTURY CIRCUIT, NORWEST NSW
Name
Mitarbeiter
12
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
IXHL's Discussions on Twitter

Compare IXHL vs TAK, ZTS, HLN, TEVA, UTHR

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
IXHL
Incannex Healthcare Inc
3.2301 36.79M 0 -21.91M 0 -1.49
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
17.82 56.14B 29.85B 776.90M 4.35B 0.2408
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
114.83 48.74B 9.47B 2.67B 2.28B 6.0218
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.06 44.85B 14.54B 2.22B 2.58B 0.4879
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
28.82 34.12B 17.41B 1.43B 1.00B 1.2182
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
537.44 23.35B 3.13B 1.27B 1.12B 26.39

Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten

pulisher
01:14 AM

Why did IXHL stock slump 20% in pre-market today? - MSN

01:14 AM
pulisher
Mar 12, 2026

IHL.AX Incannex Healthcare (ASX) A$0.041 intraday 13 Mar 2026: Phase 2 news drives volume - Meyka

Mar 12, 2026
pulisher
Mar 12, 2026

Will Incannex Healthcare Inc benefit from AI trends2026 Retail Activity & Low Risk High Win Rate Stock Picks - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 12, 2026

Incannex Updates Clinical Pathway for Sleep Apnea Drug Candidate IHL-42X - Sleep Review

Mar 12, 2026
pulisher
Mar 12, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Mar 12, 2026
pulisher
Mar 12, 2026

Incannex plans dose-optimization study for sleep apnea drug - Investing.com Nigeria

Mar 12, 2026
pulisher
Mar 12, 2026

Incannex Stock Slides As $10 Million Capital Raise Funds Next Study For Sleep Apnea Treatment - Benzinga

Mar 12, 2026
pulisher
Mar 12, 2026

Incannex Strengthens Clinical Development Pathway for IHL-42X Following Positive Phase 2 Outcomes - Bitget

Mar 12, 2026
pulisher
Mar 12, 2026

Why Did IXHL Stock Slump 20% In Pre-Market Today? - Asianet Newsable

Mar 12, 2026
pulisher
Mar 12, 2026

Incannex prices 2M shares at $5.00 in registered direct offering - TipRanks

Mar 12, 2026
pulisher
Mar 12, 2026

Incannex Healthcare prices $10M registered direct offering - MSN

Mar 12, 2026
pulisher
Mar 12, 2026

Incannex announces enhanced development strategy for IHL-42X - TipRanks

Mar 12, 2026
pulisher
Mar 12, 2026

Why Did IXHL Stock Slump 35% Today? - Stocktwits

Mar 12, 2026
pulisher
Mar 12, 2026

Incannex Healthcare Inc Shares Drop 20% After $10 Million Placement Announcement - Intellectia AI

Mar 12, 2026
pulisher
Mar 12, 2026

Incannex Highlights Enhanced Phase 2 Study and Updates - TipRanks

Mar 12, 2026
pulisher
Mar 12, 2026

Incannex Healthcare Inc. (NASDAQ: IXHL) officially announced that the company has completed the pricing of a registered direct offering with a total size of 10 million dollars. - Bitget

Mar 12, 2026
pulisher
Mar 12, 2026

Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times

Mar 12, 2026
pulisher
Mar 12, 2026

Incannex plans dose-optimization study for sleep apnea drug By Investing.com - Investing.com UK

Mar 12, 2026
pulisher
Mar 12, 2026

Incannex $10M raise funds DReAMzz Phase 2 trial, preserves Phase 3 cash - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

Sleep apnea pill from Incannex cut apnea events by up to 83% in trial - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

IXHL Stock Rips To Best Day In 5 Months: Nasdaq Compliance Back In Sight As FDA Catalyst For Sleep Apnea Drug Looms - Stocktwits

Mar 12, 2026
pulisher
Mar 11, 2026

Should I trade or invest in Incannex Healthcare IncEarnings Overview Summary & Daily Stock Trend Reports - baoquankhu1.vn

Mar 11, 2026
pulisher
Mar 10, 2026

Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

IXHL Stock Price, Quote & Chart | INCANNEX HEALTHCARE INC (NASDAQ:IXHL) - ChartMill

Mar 10, 2026
pulisher
Mar 07, 2026

How Incannex Healthcare Inc. stock compares to market leadersJuly 2025 Spike Watch & Safe Capital Preservation Plans - Naître et grandir

Mar 07, 2026
pulisher
Mar 07, 2026

Tech Rally: Will Incannex Healthcare Inc benefit from seasonalityWeekly Gains Summary & Entry Point Strategy Guides - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

Investor Mood: Can Incannex Healthcare Inc sustain earnings growth2025 Momentum Check & Community Verified Watchlist Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Why Is Incannex Healthcare Stock Surging Today? - MSN

Mar 06, 2026
pulisher
Mar 03, 2026

Incannex Healthcare Inc. (IXHL) Implements 1-for-30 Reverse Split Effective February 26 - Finviz

Mar 03, 2026
pulisher
Mar 02, 2026

ASX 200 Watch: High Volume Shakes Incannex Healthcare - Kalkine Media

Mar 02, 2026
pulisher
Feb 28, 2026

Incannex Healthcare (NASDAQ:IXHL) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Feb 28, 2026
pulisher
Feb 27, 2026

IXHL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 27, 2026
pulisher
Feb 27, 2026

Incannex Healthcare (NASDAQ:IXHL) Stock Price Down 11%What's Next? - MarketBeat

Feb 27, 2026
pulisher
Feb 26, 2026

IHL.AX Incannex ASX pre-market 27 Feb 2026: Most active A$0.041, reverse split - Meyka

Feb 26, 2026
pulisher
Feb 26, 2026

Incannex Healthcare Announces 1-for-30 Reverse Stock Split - The Globe and Mail

Feb 26, 2026
pulisher
Feb 25, 2026

Incannex to effect 1-for-30 reverse stock split to regain Nasdaq compliance - MSN

Feb 25, 2026
pulisher
Feb 25, 2026

Incannex approves 1-for-30 reverse stock split to meet Nasdaq rules - Investing.com Australia

Feb 25, 2026
pulisher
Feb 25, 2026

Why Did IXHL Stock Tank Over 32% Today? - Stocktwits

Feb 25, 2026
pulisher
Feb 25, 2026

Incannex Healthcare stock tumbles on reverse stock split news - Investing.com South Africa

Feb 25, 2026
pulisher
Feb 25, 2026

Incannex Healthcare stock tumbles on reverse stock split news By Investing.com - Investing.com Nigeria

Feb 25, 2026
pulisher
Feb 25, 2026

Incannex Healthcare announces reverse split to satisfy Nasdaq rule | Tap to know more | Inshorts - Inshorts

Feb 25, 2026
pulisher
Feb 25, 2026

Incannex board approves 1-for-30 reverse stock split - TipRanks

Feb 25, 2026
pulisher
Feb 25, 2026

Incannex approves 1-for-30 reverse stock split to regain Nasdaq compliance - MSN

Feb 25, 2026
pulisher
Feb 25, 2026

Incannex Healthcare Inc. Announces 1-for-30 Reverse Stock Split to Regain Nasdaq Compliance - Quiver Quantitative

Feb 25, 2026
pulisher
Feb 25, 2026

Incannex Announces Reverse Stock Split - Bitget

Feb 25, 2026
pulisher
Feb 25, 2026

Incannex Healthcare approved 1-for-30 reverse stock split - marketscreener.com

Feb 25, 2026
pulisher
Feb 25, 2026

Own Incannex stock? 30 shares become 1 as reverse split hits Feb. 27 - Stock Titan

Feb 25, 2026
pulisher
Feb 25, 2026

Incannex Healthcare Inc (stock code: IXHL) announced that the company has officially approved a 1-for-30 reverse stock split plan. - Bitget

Feb 25, 2026
pulisher
Feb 25, 2026

Reverse split shrinks Incannex (Nasdaq: IXHL) share count 30-fold - Stock Titan

Feb 25, 2026
pulisher
Feb 24, 2026

Trend Review: How does Incannex Healthcare Inc compare to its peers2025 Bull vs Bear & AI Forecast for Swing Trade Picks - baoquankhu1.vn

Feb 24, 2026

Finanzdaten der Incannex Healthcare Inc-Aktie (IXHL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$22.91
price up icon 0.81%
drug_manufacturers_specialty_generic RGC
$23.30
price up icon 0.00%
drug_manufacturers_specialty_generic RDY
$14.12
price down icon 1.64%
$130.01
price up icon 1.75%
$13.86
price up icon 0.90%
$537.49
price up icon 1.12%
Kapitalisierung:     |  Volumen (24h):